Search Results 1461-1470 of 17899 for monoclonal antibody
Treatment with an investigational drug or device within 30 days of study entry or any prior exposure to a monoclonal antibody targeting the CGRP pathway.
... monoclonal antibody, including humanized or chimeric antibodies. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to ...
ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can ...
The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...
Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...
Both chimeric antigen receptor (CAR)-T cell and bispecific antibody (BsAb) as T cell-directed therapies have yielded impressive clinical responses in people ...
... monoclonal antibodies. Prior exposure, without adequate treatment washout period before randomization, defined in Table 7. See Protocol. Prior exposure to ...
A recent Mayo Clinic study reveals melanoma is often detected later in people with darker skin complexions. Latest stories. Convalescent plasma antibody levels ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!